The mobilization failure was associated with limited survival. Nonetheless, collected products offered perspectives for ex vivo expansion. Further studies should investigate the feasibility of expanding collected CD34+ cells to use as grafts for ASCT.
Hematology Transfusion and Cell Therapy Template
Write in a clean editor, then format for Hematology Transfusion and Cell Therapy in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Hematology Transfusion and Cell Therapy format
Hematology Transfusion and Cell Therapy is a peer-reviewed journal published by Elsevier, covering Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research, Blood donation and transfusion practices.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Hematology Transfusion and Cell Therapy 12 (2023) 45–58.
Formats any DOI in Hematology Transfusion and Cell Therapy style. No sign-up. |
| Publishes research in | Hemoglobinopathies and Related Disorders Acute Myeloid Leukemia Research Blood donation and transfusion practices Chronic Lymphocytic Leukemia Research Acute Lymphoblastic Leukemia research |
| ISSN | 2531-1379 |
| Citation impact (2-yr) | 0.1 |
| h-index | 30 |
| i10-index | 180 |
| Total citations | 7,867 |
| Open access | Yes |
| Top institutions publishing here | Universidade Estadual de Campinas (UNICAMP) |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Hematology Transfusion and Cell Therapy per year
Citation impact of Hematology Transfusion and Cell Therapy by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Hematology Transfusion and Cell Therapy
Multiple lines of evidence indicate that the male sex is a significant risk factor for severe disease and mortality due to coronavirus disease 2019 (COVID-19). However, the precise explanation for the discrepancy is currently unclear. Immunologically, the female-biased protection against COVID-19 could presumably be due to a more rapid and robust immune response to viruses…
BACKGROUND: Preeclampsia is one of the major health problems causing maternal morbidity and mortality, complicating 3-8% of pregnancies. It has been suggested that the alterations in the coagulation and fibrinolysis play a role in the pathogenesis of preeclampsia. The markers of platelet activation include platelet count, platelet distribution width, mean platelet volume and plateletcrit. STUDY…
OBJECTIVE: To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. METHODS: The number of deaths, the mortality rate and the causes of deaths in patients with sickle cell anemia who were treated and followed up at our institution for 15 years were determined and compared…
BACKGROUND: Zika, a disease caused by Zika virus infections, has recently emerged and caused outbreaks in many parts of the world. The clinical manifestations of Zika are usually mild, mostly presenting as an exanthematic febrile disease, but on some occasions, it might be associated with microcephaly after intrauterine infection, and Guillain-Barré Syndrome. Zika virus is…